FDA panel approves expanded use of peptides in compounding pharmacies, raising concerns about prescription surge in billion-dollar industry.
Unusual Whales
The committee approved expanding the utilization of peptides in lightly regulated compounding pharmacies, which are now part of a multibillion-dollar industry.
